Winton Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-36,273
| Closed | -$2.53M | – | 1544 |
|
|
2020
Q2 | $2.53M | Sell |
36,273
-23,006
| -39% | -$1.61M | 0.07% | 531 |
|
|
2020
Q1 | $2.69M | Buy |
59,279
+7,755
| +15% | +$352K | 0.07% | 468 |
|
|
2019
Q4 | $3.35M | Buy |
51,524
+24,170
| +88% | +$1.57M | 0.05% | 606 |
|
|
2019
Q3 | $1.7M | Buy |
+27,354
| New | +$1.7M | 0.02% | 631 |
|
|
2018
Q2 | – | Sell |
-11,239
| Closed | -$1.16M | – | 1104 |
|
|
2018
Q1 | $1.16M | Buy |
+11,239
| New | +$1.16M | 0.03% | 459 |
|